Major Publishers File Second Lawsuit Against ResearchGate

As the American Chemical Society and Elsevier move litigation forward, other academic publishers have opted to collaborate with the academic network platform instead.

Written byDiana Kwon
| 4 min read
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ResearchGate, a popular networking platform where scientists can post their published work, has a complicated relationship with academic publishers. A number of them have accused the site of illicitly disseminating copyrighted work, and two of these—Elsevier and the American Chemical Society—filed a lawsuit in Germany last year to try to force ResearchGate to change its practices.

The pair has now escalated the legal battle by pursing a second case in the United States. At the same time, some publishers have opted for different approach: choosing to collaboratively address copyright issues with the platform rather than fighting it in court.

“We feel that [ResearchGate] should take responsibility for what they upload and what they allow users to upload,” says James Milne, the spokesperson for the Coalition for Responsible Sharing, a group of publishers that have taken an adversarial stance against ResearchGate. “Their view is, I believe, that they feel that they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies